Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Valeo Pharma (OtherVPHIF) and AbbVie (ABBV)
TipRanksFeb 5 08:01 ET
Stefan Quenneville Reiterates Buy Rating for Valeo Pharma Amid Positive Business Developments and Growth Potential
TipRanksJan 30 20:15 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Legend Biotech (LEGN) and Valeo Pharma (OtherVPHIF)
TipRanksNov 20, 2023 15:40 ET
Echelon Wealth Partners Sticks to Its Buy Rating for Valeo Pharma (VPHIF)
TipRanksSep 14, 2023 12:45 ET
Analysts Are Bullish on These Healthcare Stocks: Valeo Pharma (VPHIF), ADC Therapeutics (ADCT)
TipRanksSep 1, 2023 07:50 ET
Valeo Pharma (VPHIF) Gets a Buy From Echelon Wealth Partners
TipRanksJun 14, 2023 13:55 ET
Echelon Wealth Partners Sticks to Their Buy Rating for Valeo Pharma (VPHIF)
TipRanksMay 25, 2023 12:05 ET
Echelon Wealth Partners Remains a Buy on Valeo Pharma (VPHIF)
TipRanksMar 16, 2023 10:31 ET
Valeo Pharma (VPHIF) Gets a Buy From Echelon Wealth Partners
TipRanksMar 8, 2023 18:41 ET
Valeo Cut to Equalweight From Overweight by Barclays Capital
Dow JonesJul 6, 2022 05:29 ET
Valeo Target Cut to EUR20 From EUR25 by Barclays Capital
Dow JonesJul 6, 2022 05:29 ET
No Data
No Data